Evidence map›Paper›PMID 35646833›Full record

ReviewFrontiers in bioengineering and biotechnology2022

Interactions Between Immunomodulatory Biomaterials and Immune Microenvironment: Cues for Immunomodulation Strategies in Tissue Repair.

Yi Chen, Weiyan Sun, Hai Tang, Yingze Li, Chen Li, Long Wang, Jiafei Chen, Weikang Lin, Shenghui Li, Ziwen Fan and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Frontiers in bioengineering and biotechnology · 2023
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yi ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Weiyan SunDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Hai TangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Yingze LiDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Chen LiSchool of Materials Science and Engineering, Tongji University, Shanghai, China.
Long WangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Jiafei ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Weikang LinDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Shenghui LiDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Ziwen FanDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Yu ChengInstitute for Regenerative Medicine, Institute for Translational Nanomedicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Chang ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Tongji University · CNShanghai Pulmonary Hospital · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The foreign body response (FBR) caused by biomaterials can essentially be understood as the interaction between the immune microenvironment and biomaterials, which has severely impeded the application of biomaterials in tissue repair. This concrete interaction occurs via cells and bioactive substances, such as proteins and nucleic acids. These cellular and molecular interactions provide important cues for determining which element to incorporate into immunomodulatory biomaterials (IMBs), and IMBs can thus be endowed with the ability to modulate the FBR and repair damaged tissue. In terms of cellular, IMBs are modified to modulate functions of immune cells, such as macrophages and mast cells. In terms of bioactive substances, proteins and nucleic acids are delivered to influence the immune microenvironment. Meanwhile, IMBs are designed with high affinity for spatial targets and the ability to self-adapt over time, which allows for more efficient and intelligent tissue repair. Hence, IMB may achieve the perfect functional integration in the host, representing a breakthrough in tissue repair and regeneration medicine.

Indexed as

foreign body responseimmune microenvironmentimmunomodulatory biomaterialsself-adaptive interactiontissue repair

Identifiers

PMID35646833
PMCPMC9140325
OpenAlexW4280623005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.